# Palmitoylethanolamide and Luteolin in Patients with Acute Ischemic Stroke

> **NCT06777680** · NA · NOT_YET_RECRUITING · sponsor: **Ospedali Riuniti Trieste** · enrollment: 60 (estimated)

## Conditions studied

- Acute Ischemic Stroke AIS

## Interventions

- **DIETARY_SUPPLEMENT:** co-ultramicronized Palmitoylethanolamide + Luteolin (770 mg)
- **OTHER:** Placebo
- **PROCEDURE:** Thrombectomy

## Key facts

- **NCT ID:** NCT06777680
- **Lead sponsor:** Ospedali Riuniti Trieste
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06777680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06777680, "Palmitoylethanolamide and Luteolin in Patients with Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06777680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*